Lingzhi Li

机构：Stomatology Hospital · ORCID：0000-0002-6185-3467

发表论文 35 篇 · 总被引 714 次 · h-index 13

代表论文

• FFAR4 improves the senescence of tubular epithelial cells by AMPK/SirT3 signaling in acute kidney injury (2022 · Signal Transduction and Targeted Therapy · 被引 119)
• The role of two-component regulatory system in β-lactam antibiotics resistance (2018 · Microbiological Research · 被引 85)
• Circ_0080425 inhibits cell proliferation and fibrosis in diabetic nephropathy via sponging miR‐24‐3p and targeting fibroblast growth factor 11 (2019 · Journal of Cellular Physiology · 被引 67)
• ACSS2 gene variants determine kidney disease risk by controlling de novo lipogenesis in kidney tubules (2023 · Journal of Clinical Investigation · 被引 50)
• Expression profile of plasma microRNAs and their roles in diagnosis of mild to severe traumatic brain injury (2018 · PLoS ONE · 被引 46)
• Metabolic and epigenetic reprogramming in the arsenic-induced cancer stem cells (2019 · Seminars in Cancer Biology · 被引 45)